BSE filing, NSE: KKPLASTICK. Summary written from the filing by ALFA Finder's alert engine.
Kkalpana Plastick Ltd: key numbers
- Share price
- ₹54.40
- Market cap
- ₹30.08 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- -1048.0×Sector 52.0×
- Promoter holding
- 72.58%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kkalpana Plastick Ltd
All →Kkalpana Plastick Promoter Reclassification
Kkalpana Plastick reports promoters Bbigplas Poly and Sarla Surana reclassified to public after Ashish Begwani's open offer. Begwani, acquiring 40.12 lakh shares, becomes sole promoter.
Kkalpana Plastick Promoter Buying (Off-Market)
Ashish Begwani disclosed acquiring 40,12,335 shares, 72.58% of Kkalpana Plastick, via an off-market SPA. The acquisition moves his holding from 0.01% to 72.58%.
- Promoter stake change
- +72.57%
Kkalpana Plastick Management Change
Kkalpana Plastick reported 13 management changes effective November 2026. These include new directors and a CFO, plus resignations of directors, a company secretary and auditors.
Kkalpana Plastick Q2 FY27 Results: Net Profit ₹0 Cr
Kkalpana Plastick Ltd reported net profit of ₹0 Cr for Q2 FY27.
- Key figure
- Net profit ₹0 Cr
Kkalpana Plastick Board Meeting Date
Kkalpana Plastick Ltd has scheduled a board meeting for October 27, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Kkalpana Plastick Annual General Meeting
Kkalpana Plastick Ltd filed the minutes of its 37th Annual General Meeting held on September 23, 2026. The meeting successfully concluded all ordinary and special business items.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.